Potential breakthrough for hard to treat cancers | ScienceDaily
WEB20 hours ago · KRAS is the most mutated gene in cancer with mutations occurring in 17%-25% of all cancers, affecting millions of patients worldwide. It plays a crucial role in tumour growth, as it is important ...
UMass Chan researchers develop dual therapeutic that holds …
WEB33 minutes ago · Dual treatment shows promise in fighting pancreatic cancer. Eight of nine animal models in the study experienced tumor shrinkage. Combination therapy both suppresses tumor cell defenses and activates the body’s immune system to fight off cancer cells. Related media coverage: NBC Boston. New cancer research breakthrough has potential to save ...
11 new breakthroughs in the fight against cancer - The World …
WEBJul 25, 2024 · Scientists working to improve the treatment and diagnosis of cancer are beginning to use AI, DNA sequencing and precision oncology among other techniques.
Breast cancer treatment: Drug Kisqali approval expanded for ... - NBC News
WEB6 days ago · The drug was found to reduce the risk of a patient's breast cancer coming back by 25%. The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to ...
Pembrolizumab improves outcomes in high-risk bladder cancer
WEBSep 16, 2024 · NCI Press Office. 240-760-6600. Adjuvant pembrolizumab helps people with muscle-invasive bladder cancer remain cancer-free longer than observation alone. Credit: Terese Winslow/National Cancer Institute. Results from a large clinical trial show that treatment with an immunotherapy drug may nearly …
Cancer-fighting antibodies inject chemo directly into tumor cells ...
WEBJun 2, 2024 · New research on two different antibody drug conjugates, presented Sunday at the American Society of Clinical Oncology (ASCO) conference in Chicago, found that the treatments helped patients with...
FDA approves groundbreaking treatment for advanced melanoma - NBC News
WEBFeb 16, 2024 · The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated.
Lifileucel First Cellular Therapy Approved for Cancer
WEBMar 5, 2024 · In an event more than three decades in the making, the Food and Drug Administration (FDA) has approved lifileucel (Amtagvi), the first treatment for cancer that uses immune cells called tumor-infiltrating lymphocytes, or TILs.
New cancer treatment may reawaken the immune system - MIT News
WEBOct 19, 2021 · MIT researchers have now discovered a new way to jump-start the immune system to attack tumors, which they hope could allow immunotherapy to be used against more types of cancer.
Stanford Medicine delivers first FDA-approved cell-based therapy …
WEBMay 6, 2024 · The new treatment, which uses immune cells harvested from a patient’s tumor called tumor-infiltrating lymphocytes, exploits the body’s own natural cancer-fighting ability.